國立高雄大學圖資館 |

Language: English

Back

The aggregation and membrane permeabilizing activity of alpha-synuclein

Record Type:	Electronic resources : Monograph/item
Title/Author:	The aggregation and membrane permeabilizing activity of alpha-synuclein
Author:	Volles, Michael James.
Description:	94 p.
Notes:	Adviser: Peter T. Lansbury, Jr.
Notes:	Source: Dissertation Abstracts International, Volume: 65-01, Section: B, page: 0211.
Contained By:	Dissertation Abstracts International65-01B.
Subject:	Chemistry, Biochemistry.
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3118014
ISBN:	0496654381

The aggregation and membrane permeabilizing activity of alpha-synuclein
Volles, Michael James.

The aggregation and membrane permeabilizing activity of alpha-synuclein [electronic resource] - 94 p.

Adviser: Peter T. Lansbury, Jr.

Thesis (Ph.D.)--Harvard University, 2004.

Two point mutations in the alpha-synuclein gene are genetically linked to autosomal dominant Parkinson's disease. Purified monomeric alpha-synuclein protein is unfolded in solution, but over time a small mol fraction can aggregate to form a heterogeneous mixture of beta-sheet containing soluble oligomers (termed protofibrils) which coexist with the monomeric protein. The monomer/oligomer mixture eventually proceeds to form amyloid fibrils, at which time the majority of the monomer and oligomer is consumed. It is not known which aggregation form of alpha-synuclein is neurotoxic in Parkinson's disease, nor is the pathogenic mechanism known. This thesis demonstrates that a subset of the oligomeric species are capable of permeabilizing negatively charged synthetic phospholipid vesicles via a pore-like mechanism, in vitro. The monomeric and fibrillar forms of the protein have little or no membrane permeabilizing activity, and protofibrils of the Parkinson's disease linked mutants A30P and A53T have a higher specific permeabilizing activity per mol of protein than protofibrils of wild type. Subsequently, a random mutagenesis library of sequence variants was created which codes for approximately 1.5 million different protein sequences (estimated using a new computational method described herein), with an average of two point mutations per sequence. An in vitro aggregation screen of 70 individually expressed and purified variants from the library revealed two double-point mutants which fibrillize significantly more slowly than the wild-type protein. Future examination of the in vivo neurotoxicity of these sequence variants (in a transgenic disease model) may help elucidate the nature of Parkinson's disease pathogenesis.

ISBN: 0496654381Subjects--Topical Terms:

226900
Chemistry, Biochemistry.

The aggregation and membrane permeabilizing activity of alpha-synuclein
LDR:02765nmm _2200289 _450 001 162346
005 20051017073437.5
008 230606s2004 eng d
020 $a 0496654381
035 $a 00148847
035 $a 162346
040 $a UnM $c UnM
100 0 $a Volles, Michael James. $3 227478
245 1 4 $a The aggregation and membrane permeabilizing activity of alpha-synuclein $h [electronic resource]
300 $a 94 p.
500 $a Adviser: Peter T. Lansbury, Jr.
500 $a Source: Dissertation Abstracts International, Volume: 65-01, Section: B, page: 0211.
502 $a Thesis (Ph.D.)--Harvard University, 2004.
520 # $a Two point mutations in the alpha-synuclein gene are genetically linked to autosomal dominant Parkinson's disease. Purified monomeric alpha-synuclein protein is unfolded in solution, but over time a small mol fraction can aggregate to form a heterogeneous mixture of beta-sheet containing soluble oligomers (termed protofibrils) which coexist with the monomeric protein. The monomer/oligomer mixture eventually proceeds to form amyloid fibrils, at which time the majority of the monomer and oligomer is consumed. It is not known which aggregation form of alpha-synuclein is neurotoxic in Parkinson's disease, nor is the pathogenic mechanism known. This thesis demonstrates that a subset of the oligomeric species are capable of permeabilizing negatively charged synthetic phospholipid vesicles via a pore-like mechanism, in vitro. The monomeric and fibrillar forms of the protein have little or no membrane permeabilizing activity, and protofibrils of the Parkinson's disease linked mutants A30P and A53T have a higher specific permeabilizing activity per mol of protein than protofibrils of wild type. Subsequently, a random mutagenesis library of sequence variants was created which codes for approximately 1.5 million different protein sequences (estimated using a new computational method described herein), with an average of two point mutations per sequence. An in vitro aggregation screen of 70 individually expressed and purified variants from the library revealed two double-point mutants which fibrillize significantly more slowly than the wild-type protein. Future examination of the in vivo neurotoxicity of these sequence variants (in a transgenic disease model) may help elucidate the nature of Parkinson's disease pathogenesis.
590 $a School code: 0084.
650 # 0 $a Chemistry, Biochemistry. $3 226900
650 # 0 $a Biology, Molecular. $3 226919
650 # 0 $a Health Sciences, Pathology. $3 227107
690 $a 0307
690 $a 0487
690 $a 0571
710 0 # $a Harvard University. $3 212445
773 0 # $g 65-01B. $t Dissertation Abstracts International
790 $a 0084
790 1 0 $a Lansbury, Peter T., Jr., $e advisor
791 $a Ph.D.
792 $a 2004
856 4 0 $u http://libsw.nuk.edu.tw/login?url=http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3118014 $z http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3118014